Can Keflex (cephalexin) cause impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin and Kidney Injury

Yes, cephalexin (Keflex) can cause kidney injury, though it occurs rarely compared to other antibiotics. According to the FDA drug label, cephalexin should be administered with caution in patients with markedly impaired renal function, as it may cause reversible interstitial nephritis and direct tubular toxicity 1.

Mechanisms of Kidney Injury

Cephalexin can affect the kidneys through several mechanisms:

  1. Direct tubular toxicity - Though uncommon with current cephalosporins, they can occasionally cause direct tubular damage 2
  2. Acute interstitial nephritis - An immune-mediated reaction that can occur with cephalosporins 1
  3. Altered renal clearance - Cephalexin is primarily excreted by the kidneys, with 70-100% of the dose found in urine within 6-8 hours 3

Risk Factors for Kidney Injury

Patients at higher risk for cephalexin-induced kidney injury include:

  • Those with pre-existing renal impairment
  • Elderly patients (who often have decreased renal function)
  • Patients receiving other nephrotoxic medications
  • Dehydrated patients
  • Patients with severe hepatic disease (due to predisposition to hepato-renal syndrome) 4

Clinical Evidence

A documented case report describes a 24-year-old woman who developed acute tubular necrosis after receiving cephalexin for only 4 days. Her creatinine level rose from normal to 5.3 mg/dl, though it returned to normal (0.6 mg/dl) within a month after discontinuation 2.

Pharmacokinetics in Renal Impairment

Cephalexin pharmacokinetics are significantly altered in patients with renal impairment:

  • In normal renal function, the half-life is approximately 1.03 hours
  • In patients with severely impaired renal function or on hemodialysis, the half-life can increase to 8.47 hours 5
  • Hemodialysis reduces serum concentration of cephalexin by approximately 58% 6

Monitoring and Management

For patients with impaired renal function:

  • Dose adjustment: Reduce dosage proportionally to the reduction in renal function 3
  • Monitoring: Careful clinical observation and laboratory studies are necessary 1
  • Specific recommendations: For patients with creatinine clearance less than 30 ml/min, the dose should be reduced to 250-500 mg/day 4
  • Hemodialysis considerations: For patients on hemodialysis, administer after dialysis to avoid premature removal of the drug 4

Prevention of Kidney Injury

To minimize the risk of kidney injury when using cephalexin:

  • Avoid concomitant use with other nephrotoxic drugs
  • Ensure adequate hydration
  • Monitor renal function in high-risk patients
  • Use appropriate dose adjustments based on renal function
  • Consider alternative antibiotics in patients with severe renal impairment

Clinical Implications

While cephalexin is generally considered safer for the kidneys than many other antibiotics, clinicians should remain vigilant about potential nephrotoxicity, particularly in high-risk populations. The American Journal of Kidney Diseases recommends close monitoring of patients with impaired renal function, with careful attention to fluid management and vital signs 7.

Remember that cephalexin-induced kidney injury is reversible in most cases with prompt discontinuation of the medication, but early recognition is key to preventing progression to more severe renal damage.

References

Research

Cephalexin-induced acute tubular necrosis.

Pharmacotherapy, 2004

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Infections in Patients with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.